Background<b>/</b>Objectives: Programmed death ligand 1 (PD-L1) is often overexpressed in triple-negative breast cancer (TNBC), where it helps the tumor evade the immune system and promotes tumor growth. The gene discussed is CD274; the disease is neoplasm.